PMID: 590608Jan 1, 1977

Maprotiline (Ludiomil) in depression: a multicentre assessment of onset of action, efficacy and tolerability

The Journal of International Medical Research
W A Forrest

Abstract

Although open studies have a built-in bias of optimism the results from this study, made valid by the large numbers of patients involved, support the findings reported with smaller numbers in controlled series of studies showing an early onset of action with maprotiline (Ludiomil). The method used in this study to detect unwanted effects indicates that maprotiline is well tolerated. In summary, the efficacy of once daily dosage, the good response in differing types of depressive illness, the early onset of effectiveness without serious side-effects in a wide age range of patients suggests that this drug will be a useful addition for the treatment of depressive illness in general practice.

Related Concepts

Transient Situational Disturbance
Anthrones
Depressive Symptoms
Maprotilin von ct

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.